Skip to content

Rejuvel Bio-Sciences, Inc.: 10-K/A filed 2014-04-24

What Rejuvel Bio-Sciences, Inc. reported in its annual report amendment filed 2014-04-24 (fiscal FY 2013): 30 published measures, 80 facts as tagged in accession 0001469709-14-000151.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-K/A (annual report amendment)
Filed
2014-04-24
Fiscal period
fiscal FY 2013
Accession
0001469709-14-000151 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Rejuvel Bio-Sciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-31105,973USD
At 2012-12-31315,430USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-311,207,335USD
At 2012-12-31782,325USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-1,101,362USD
At 2012-12-31-466,895USD
At 2011-12-31-29,816USD
At 2010-12-31-24,346USD
At 2009-12-31-2,575USD
At 2009-10-130USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-314,891USD
At 2012-12-31120,697USD
At 2011-12-31170,363USD
At 2009-10-150USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-715,546USD365
2009-10-16 to 2013-12-31-1,804,909USD1538
2012-01-01 to 2012-12-31-834,079USD366
2011-01-01 to 2011-12-31-227,838USD365
2010-01-01 to 2010-12-31-24,871USD365
2009-10-14 to 2009-12-31-2,575USD79

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-297,964USD365
2009-10-16 to 2013-12-31-1,121,316USD1538
2012-01-01 to 2012-12-31-678,982USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-01-01 to 2013-12-3151,559USD365
2009-10-16 to 2013-12-3161,038USD1538
2012-01-01 to 2012-12-317,979USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-31192,158USD365
2009-10-16 to 2013-12-311,244,931USD1538
2012-01-01 to 2012-12-31625,786USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-10,000USD365
2009-10-16 to 2013-12-31-33,723USD1538
2012-01-01 to 2012-12-31-470USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-1,804,909USD
At 2012-12-31-1,089,363USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-529,706USD365
2009-10-16 to 2013-12-311,462,755USD1538
2012-01-01 to 2012-12-31-677,765USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3184,662USD
At 2012-12-31299,919USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-31197,452USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-311,207,335USD
At 2012-12-31782,325USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-310USD
At 2012-12-310USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-3170,862USD
At 2012-12-31125,408USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-3124,754USD365
2009-10-16 to 2013-12-3129,739USD1538
2012-01-01 to 2012-12-314,110USD366

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-01-01 to 2013-12-3126,805USD365
2009-10-16 to 2013-12-3131,299USD1538
2012-01-01 to 2012-12-313,869USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-318,319USD365
2012-01-01 to 2012-12-317,700USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-31117,348,000shares
At 2012-12-31117,248,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-31586,199USD
At 2012-12-31505,220USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-31-12,282USD
At 2012-12-31-8,191USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-12-311,940USD
At 2012-12-312,049USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-12-310USD
At 2012-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31554,460USD365
2009-10-16 to 2013-12-311,492,494USD1538
2012-01-01 to 2012-12-31681,875USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-01-01 to 2013-12-31109USD365
2012-01-01 to 2012-12-31101USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2009-10-16 to 2013-12-31509,250USD1538
2012-01-01 to 2012-12-31397,000USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2009-10-16 to 2013-12-310USD1538
2012-01-01 to 2012-12-310USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2009-10-16 to 2013-12-31-70,862USD1538
2012-01-01 to 2012-12-310USD366

Inspect the source

Entity
Rejuvel Bio-Sciences, Inc. / CIK 0001481427
Captured
SEC response SHA-256
4a018d6151ebf80d4c67ed9e7073ee9a3240164f46be0f2dea7bcfa00e98d7fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001481427.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))